Canada
· Delayed Price · Currency is CAD Diagnamed Holdings Company Description
Diagnamed Holdings Corp., a digital health artificial intelligence company, engages in the development and commercialization of digital therapeutics for people suffering from mental health and neurological disorders.
It focuses on CERVAI, a brain health AI platform; and Health GenAI, a suite of generative AI solutions for the healthcare market that includes OpenAI's ChatGPT.
The company also develops Dr. GENAI, a personal AI medical chatbot designed to give people to obtain fast and personalized medical information based on a person’s unique medical condition.
In addition, the company developing Brain Age, an electroencephalogram-based (EEG) machine-learning solution to detect an individual’s brain age for use in clinic and at-home.
It has a collaboration agreement with EIREX technology for the development and commercialization of EIREX’s novel modular carbon-free technology that extracts hydrogen from water.
The company is headquartered in Toronto, Canada.
| Country | Canada |
| Industry | Health Information Services |
| Sector | Healthcare |
| CEO | Fabio Chianelli |
Contact Details
Address: 82 Richmond Street East Toronto, British Columbia M5C 1P1 Canada | |
| Phone | 416 800 2684 |
| Website | diagnamed.com |
Stock Details
| Ticker Symbol | DMED |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | October - September |
| Reporting Currency | CAD |
| ISIN Number | CA25245D1033 |
| SIC Code | 7372 |
Key Executives
| Name | Position |
|---|---|
| Fabio Chianelli | Chairman, President and Chief Executive Officer |
| Jing Peng C.A., CPA, CA, CPA, MMPA | Chief Financial Officer |
| Andrew Newbury CPA | Corporate Secretary |